Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended June 2024 as against Rs 0.02 crore during the previous quarter ended June 2023. Sales reported to Rs 0.10 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023.
| Particulars | Quarter Ended | ||
| Jun. 2024 | Jun. 2023 | % Var. | |
| Sales | 0.10 | 0 | 0 |
| OPM % | -20.00 | 0 | - |
| PBDT | 0.01 | 0.02 | -50 |
| PBT | 0.01 | 0.02 | -50 |
| NP | 0.01 | 0.02 | -50 |
